Genotype-dependent differences in sleep, vigilance, and response to stimulants

Current Pharmaceutical Design

Volumn 14, Issue 32, 2008, Pages 3396-3407

  Landolt, Hans Peter ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adenosine; Candidate gene; Dopamine; Genome wide association; Modafinil; PER3; Pharmacogenetics; Serotonin

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 AMINOBUTYRIC ACID; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CAFFEINE; CASEIN KINASE II; CASEIN KINASE II ALPHA2; CATECHOL METHYLTRANSFERASE; CENTRAL STIMULANT AGENT; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; GALANIN; MODAFINIL; PER1 PROTEIN; PER2 PROTEIN; SEROTONIN; SEROTONIN TRANSPORTER; TRANSCRIPTION FACTOR CLOCK; UNCLASSIFIED DRUG;

ALERTNESS; ANXIETY DISORDER; CIRCADIAN RHYTHM SLEEP DISORDER; DAYTIME SOMNOLENCE; DIZYGOTIC TWINS; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG TARGETING; ELECTROENCEPHALOGRAPHY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN GENETICS; MISSENSE MUTATION; MONOZYGOTIC TWINS; NARCOLEPSY; NERVE CELL NETWORK; NEUROANATOMY; NEUROCHEMISTRY; NIGHT SLEEP; NONHUMAN; NONREM SLEEP; OPTIMAL DRUG DOSE; PHARMACOGENETICS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP PATTERN; SLEEP STAGE; SLEEP TIME; SLEEP WAKING CYCLE; WAKEFULNESS; DRUG EFFECT; GENE; GENETICS; SLEEP;

CENTRAL NERVOUS SYSTEM STIMULANTS; GENES; GENOTYPE; HUMANS; SLEEP; WAKEFULNESS;

EID: 58949084207     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786549344     Document Type: Review

References (158)

1. Borbély AA. A two process model of sleep regulation. Hum Neurobiol 1982;1:195-204.
2. Dijk D-J, Czeisler CA. Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci 1995; 15: 3526-38.
3. Borbély AA, Achermann P. In: Kryger MH, Roth T, Dement WC Eds, Principles and Practice of Sleep Medicine. Philadelphia, PA: Elsevier Saunders 2005; 405-17.
4. Dijk DJ, von Schantz M. Timing and consolidation of human sleep, wakefulness, and performance by a symphony of oscillators. J Biol Rhythms 2005; 20: 279-90.
5. Schmidt C, Collette F, Cajochen C, Peigneux P. A time to think: Circadian rhythms in human cognition. Cogn Neuropsych 2007; 24: 755-89.
6. Lim.JL, Dinges DF. Sleep deprivation and vigilant attention. Ann N Y Acad Sci 2008; 1129: 305-22.
7. Wirz-Justice A, Van den Hoofdakker RH. Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry 1999; 46: 445-53.
8. Barnard AR, Nolan PM. When clocks go bad: Neurobehavioural consequences of disrupted circadian timing. PLoS Genetics 2008; 4:
9. Horne JA, Östberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976; 4: 97-110.
10. Torsvall L, Akerstedt T. A diurnal type scale. Scand J Work Environ Health 1980; 6: 283-90.
11. Mishima K, Tozawa T, Satoh K, Saitoh H, Mishima Y. The 3111 T/C polymorphisin of hClock is associated with evening preference and delayed sleep timing in a Japanese population sample. Am J Med Genet B Neuropsychiatr Genet 2005; 133B: 101-4.
12. Koskenvuo M, Hublin C, Partinen M, Heikkila K, Kaprio J. Heritability of diurnal type: A nationwide study of 8753 adult twin pairs. J Sleep Res 2007; 16: 156-62.
13. Aeschbach D, Sher L, Postolache TT, Matthews JR, Jackson MA, Wehr TA. A longer biological night in long sleepers than in short sleepers. J Clin Endocrinol Metab 2003; 88: 26-30.
14. Aeschbach D, Cajochen C, Landolt HP, Borbély AA. Homeostatic sleep regulation in habitual short sleepers and long sleepers. Am J Physiol 1996; 270: R41-53.
15. Aeschbach D, Postolache TT, Sher L, Matthews JR, Jackson MA, Wehr TA. Evidence from the waking electroencephalogram that short sleepers live under higher homeostatic sleep pressure than long sleepers. Neuroscience 2001; 102: 493-502.
16. 2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther 2007; 81: 692-8.
17. Gedda L, Brenci G. Sleep and dream characteristics in twins. Acta Genet Med Gemellol 1979; 28(3): 237-9.
18. Partinen M, Kaprio J, Koskenvuo M, Putkonen P, Langinvainio H. Genetic and environmental determination of human sleep. Sleep 1983; 6: 179-85
19. Heath AC, Kendler KS, Eaves LJ, Martin NG. Evidence for genetic influences on sleep disturbance and sleep pattern in twins. Sleep 1990; 13: 318-35.
20. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects, National Institutes of Health: Bethesda, Maryland; 1968.
21. Merica H, Gaillard JM. Statistical description and evaluation of the interrelationships of standard sleep variables for normal subjects. Sleep 1985; 8: 261-73.
22. Tan X, Campbell IG, Feinberg I. Internight reliability and benchmark values for computer analyses of non-rapid eye movement (NREM) and REM EEG in normal young adult and elderly subjects. Clin Neurophysiol 2001; 112: 1540-52.
23. Buckelmüller J, Landolt HP, Stassen HH, Achermann P. Trait-like individual differences in the human sleep electroencephalogram. Neuroscience 2006; 138: 351-6.
24. Tucker AM, Dinges DF, Van Dongen HPA. Trait interindividual differences in the sleep physiology of healthy young adults. J Sleep Res 2007; 16: 170-80.
25. Zung WW, Wilson WP. Sleep and dream patterns in twins. Markov analysis of a genetic trait. Recent Adv Biol Psychiatry 1966; 9: 119-30.
26. Webb WB, Campbell SS. Relationships in Sleep Characteristics of Identical and Fraternal-Twins. Arch Gen Psychiatry 1983; 40: 1093-5.
27. Chouvet G, Blois R, Debilly G, Jouvet M. La structure d'occurrence des mouvements oculaires rapides du sommeil paradoxal est similaire chez les jumeaux homozygotes. C R Acad Sc Paris III 1983; 296: 1063-8.
28. Linkowski P. EEG sleep patterns in twins. J Sleep Res 1999; 8 Suppl 1: 11-3.
29. Borbély AA, Baumann F, Brandeis D, Strauch I, Lehmann D. Sleep deprivation: Effect on sleep stages and EEG power density man. Electroencephatogr Clin Neurophysiol 1981; 51: 483-93.
30. Geering BA, Achermann P, Eggimann F, Borbély AA. Period-amplitude analysis and power spectral analysis: A comparison based on all-night sleep EEG recordings. J Sleep Res 1993; 2: 121-9.
31. Ambrosius U, Lietzenmaier S, Wehrle R, Wichniak A, Kalus S, Winkelmann J, et al. Heritability of sleep electroencephalogram. Biol Psychiatry 2008; 64; 344-8.
32. De Gennaro L, Marzano C, Fratello F, Moroni F, Pellicciari MC, Ferlazzo F, et al. The EEG fingerprint of sleep is genetically determined: a twin study. Ann Neurol 2008; 64(4): 455-60.
33. Lennox WG, Gibbs EL, Gibbs FA. The brain-wave pattern, an hereditary trait - evidence from 74 normal pairs of twins. J Heredity 1945; 36: 233-43.
34. Vogel F. Ueber die Erblichkeit des normalen Elektroenzephalogramms: Vergleichende Untersuchungen an ein- und zweieiigen Zwillingen, Georg Thieme Verlag: Stuttgart; 1958.
35. Juel-Nielson N, Harvald B. The electroencephalogram in uniovular twins brought up apart. Acta Genet 1958; 8: 57-64.
36. Stassen HH, Bomben G, Propping P. Genetic aspects of the EEG: An investigation into the within-pair similarity of monozygotic and dizygotic twins with a new method of analysis. Electroencephalogr clin Neurophysiol 1987; 66: 489-501.
37. van Beijsterveldt CE, Molenaar PC, de Geus EJ, Boomsma DI. Heritability of human brain functioning as assessed by electro-encephalography. Am J Hum Genet 1996; 58: 562-73.
38. Borbély AA. In: Koukkou M, Lehmann D, Angst J, Eds., Functional states of the brain: Their determinants. Amsterdam, Elsevier 1980; 151-61.
39. Tobler I. In: Kryger MH, Roth T, Dement WC, Eds., Principles and Practice of Sleep Medicine. Philadelphia, PA, Elsevier Saunders 2005; 77-90.
40. Dijk DJ, Beersma DGM, Daan S. EEG power density during nap sleep: reflection of an hourglass measuring the duration of prior wakefulness. J Biol Rhythms 1987; 2: 207-19.
41. Rétey JV, Adam M, Gottselig JM, Khatami R, Dürr R, Achermann P, et al. Adenosinergic mechanisms contribute to individual differences in sleep-deprivation induced changes in neurobehavioral function and brain rhythmic activity. J Neurosci 2006; 26: 10472-9.
42. Knoblauch V, Martens WL, Wirz-Justice A, Cajochen C. Human sleep spindle characteristics after sleep deprivation. Clin Neurophysiol 2003; 114: 2258-67.
43. Torsvall L, Åkerstedt T. Sleepiness on the job: Continuously measured EEG changes in train drivers. Electroencephalogr clin Neurophysiol 1987; 66: 502-11.
44. Cajochen C, Brunner DP, Krüauchi K, Graw P, Wirz-Justice A. Power density in theta/alpha frequencies of the waking EEG progressively increases during sustained wakefulness. Sleep 1995; 18: 890-4.
45. Aeschbach D, Matthews JR, Postolache TT, Jackson MA, Giesen HA, Wehr TA. Dynamics of the human EEG during prolonged wakefulness: Evidence for frequency-specific circadian and homeostatic influences. Neurosci Lett 1997; 239: 121-4.
46. Finelli LA, Baumann H, Borbély AA, Achermann P. Dual electroencephalogram markers of human sleep homeostasis: Correlation between theta activity in waking and slow-wave activity in sleep. Neuroscience 2000; 101: 523-9.
47. Finelli LA, Acherman P, Borbely AA. Individual 'fingerprints' in human sleep EEG topography. Neuropsychopharmacology 2001; 25(Suppl 5): S57-62.
48. De Gennaro L, Ferrara M, Vecchio F, Curcio G, Bertini M. An electroencephalographic fingerprint of human sleep. NeuroImage 2005; 26: 114-22.
49. Van Dongen HP, Maislin G, Mullington JM, Dinges DF. The cumulative cost of additional wakefulness: Dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003; 26: 117-26.
50. Leproult R, Colecchia EF, Berardi AM, Stickgold R, Kosslyn SM, Van Cauter E. Individual differences in subjective and objective alertness during sleep deprivation are stable and unrelated. Am J Physiol 2003; 284: R280-90.
51. Frey DJ, Badia P, Wright KP. Inter- and intra-individual variability in performance near the circadian nadir during sleep deprivation. J Sleep Res 2004; 13: 305-15.
52. Galliaudi E, Taillard J, Sagaspei P, Valtati C, Bioulac B, Philip P. Sharp and sleepy: Evidence for dissociation between sleep pressure and nocturnal performance. J Sleep Res 2008; 17: 11-5.
53. Van Dongen HPA, Baynard MD, Maislin G, Dinges DF. Systematic interindividual differences in neurobehavioral impairment from sleep loss: Evidence of trait-like differential vulnerability. Sleep 2004; 27: 423-33.
54. Van Dongen HP, Vitellaro KM, Dinges DF. Individual differences in adult human sleep and wakefulness: Leitmotiv for a research agenda. Sleep 2005; 28: 479-96.
55. Shaw PJ, Franken P. Perchance to dream: Solving the mystery of sleep through genetic analysis. J Neurobiol 2003; 54: 179-202.
56. Tafti M, Maret S, Dauvilliers Y. Genes for normal sleep and sleep disorders. Ann Med 2005; 37: 580-9.
57. Wisor JP, Kilduff TS. Molecular genetic advances in sleep research and their relevance to sleep medicine. Sleep 2005; 28: 357-67.
58. Tafti M, Franken P. Invited review: Genetic dissection of sleep. J Appl Physiol 2002; 92: 1339-47.
59. Franken P, Tafti M. Genetics of sleep and sleep disorders. Front Biosci 2003; 8: E381-97.
60. Steriade M. The corticothalamic system in sleep. Front Biosci 2003; 8: 878-99.
61. Jones BE. From waking to sleeping: Neuronal and chemical substrates. Trends Pharm Sci 2005; 26: 578-86.
62. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005; 437: 1257-63.
63. Stenberg D. Neuroanatomy and neurochemistry of sleep. Cell Mol Life Sci 2007; 64: 1187-204.
64. Porkka-Heiskanen T, Strecker RE, Thakkar M, Bjorkum AA, Greene RW, McCarley RW. Adenosine: A mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997; 276: 1265-8.
65. Porkka-Heiskanen T, Strecker RE, McCarley RW. Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: An in vivo microdialysis study. Neuroscience 2000; 99: 507-17.
66. McCarley RW. Neurobiology of REM and NREM sleep. Sleep Med 2007; 8: 302-30.
67. Siegel J, Radulovacki M, Heller HC, Alam MN, Szymusiak R, McGinty D, et al. Commentaries on: Blanco-Centurion C, Xu M, Murillo-Rodriguez E et al. Adenosine and sleep homeostasis in the basal forebrain. J Neurosci 26(31): 8092-8100, August 2, 2006. Sleep 2006; 29: 1381-9.
68. Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, et al. Sleep deprivation increases A(1) adenosine receptor binding in the human brain: A positron emission tomography study. J Neurosci 2007; 27: 2410-5.
69. Koyama Y, Hayaishi O. Firing of neurons in the preoptic/anterior hypothalamic areas in rat: Its possible involvement in slow wave sleep and paradoxical sleep. Neurosci Res 1994; 19: 31-8.
70. Szymusiak R, Alam N, Steininger TL, McGinty D. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 1998; 803: 178-88.
71. Sherin JE, Shiromani PJ, McCarley RW, Saper CB. Activation of ventrolateral preoptic neurons during sleep. Science 1996; 271: 216-9
72. Nofzinger EA, Buysse DJ, Miewald JM, Meltzer CC, Price JC, Sembrat RC, et al. Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain 2002; 125: 1105-15.
73. Gaus SE, Strecker RE, Tate BA, Parker RA, Saper CB. Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species. Neuroscience 2002; 115: 285-94.
74. Gallopin T, Fort P, Eggermann E, Cauli B, Luppi PH, Rossier J, et al. Identification of sleep-promoting neurons in vitro. Nature 2000; 404: 992-5.
75. Sherin JE, Elmquist JK, Torrealba F, Saper CB. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 1998; 18: 4705-21.
76. Lu J, Greco MA, Shiromani P, Saper CB. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 2000; 20: 3830-42.
77. Steininger TL, Gong H, McGinty D, Szymusiak R. Subregional organization of preoptic area/anterior hypothalamic projections to arousal-related monoaminergic cell groups. J Comp Neurol 2001; 429: 638-53.
78. Lu J, Bjorkum AA, Xu M, Gaus SE, Shiromani PJ, Saper CB. Selective activation of the extended ventrolateral preoptic nucleus during rapid eye movement sleep. J Neurosci 2002; 22: 4568-76.
79. Chou TC, Bjorkum AA, Gaus SE, Lu J, Scammell TE, Saper CB. Afferents to the ventrolateral preoptic nucleus. J Neurosci 2002; 22: 977-90.
80. Morairty S, Rainnie D, McCarley R, Greene R. Disinhibition of ventrolateral preoptic area sleep-active neurons by adenosine: A new mechanism for sleep promotion. Neuroscience 2004; 123: 451-7.
81. Gallopin T, Luppi PH, Cauli B, Urade Y, Rossier J, Hayaishi O, et al. The endogenous somnogen adenosine excites a subset of sleep-promoting neurons via A2A receptors in the ventrolateral preoptic nucleus. Neuroscience 2005; 134: 1377-90.
82. McCoy JG, Tartar JL, Bebis AC, Ward CP, McKenna JT, Baxter MG, et al. Experimental sleep fragmentation impairs attentional set-shifting in rats. Sleep 2007; 30: 52-60.
83. Moruzzi G, Magoun HW. Brain stem and EEG activation. Electroencephalogr clin Neurophysiol 1949; 1: 455-73.
84. Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 2003; 42: 33-84.
85. Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981; 1: 876-86.
86. Cirelli C, Huber R, Gopalakrishnan A, Southard TL, Tononi G. Locus ceruleus control of slow-wave homeostasis. J Neurosci 2005; 25: 4503-11.
87. Arnulf I. Sleep and wakefulness disturbances in Parkinson's disease. J Neural Transm Suppl 2006; 70: 357-60.
88. Lu J, Jhou TC, Saper CB. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci 2006; 26: 193-202.
89. Rang HP, Dale MM, Ritter JM, Flower R. Rang & Dale's Pharmacology, Churchill Livingstone; 2007.
90. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001; 21: 1787-94
91. Jouvet M. The role of monoammies and acetylcholine-containing neurons in the regulation of the sleep-waking cycle. Ergeb Physiol 1972; 64: 166-307.
92. Ursin R. Serotonin and sleep. Sleep Med Rev 2002; 6: 55-69.
93. McGinty DJ, Harper RM. Dorsal raphe neurons: Depression of firing during sleep in cats. Brain Res 1976; 101: 569-75.
94. Trulson ME, Jacobs BL. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res 1979; 163: 135-50.
95. Penalva RG, Lancel M, Flachskamm C, Reul JM, Holsboer F, Linthorst AC. Effect of sleep and sleep deprivation on serotonergic neurotransmission in the hippocampus: A combined in vivo microdialysis/EEG study in rats. Eur J Neurosci 2003; 17: 1896-906.
96. Portas CK McCarley RW. Behavioral state-related changes of extracellular serotonin concentration in the dorsal raphe nucleus: A microdialysis study in the freely moving cat. Brain Res 1994; 648: 306-12.
97. Zeitzer JM, Maidment NT, Behnke EJ, Ackerson LC, Fried I, Engel J, Jr., et al. Ultradian sleep-cycle variation of serotonin in the human lateral ventricle. Neurology 2002; 59: 1272-4.
98. Beelman CA, Parker R. Degradation of messenger-RNA in Eukaryotes. Cell 1995; 81: 179-83.
99. Katzenberg D, Young T, Finn L, Lin L, King DP, Takahashi JS, et al. A CLOCK polymorphism, associated with human diurnal preference. Sleep 1998; 21: 569-76.
100. Robilliard DL, Archer SN, Arendt J, Lockley SW, Hack LM, English J, et al. The 3111 Clock gene polymorphism is not associated with sleep and circadian rhythmicity in phenotypically characterized human subjects. J Sleep Res 2002; 11: 305-12.
101. Pedrazzoli M, Louzada FM, Pereira DS, Benedito-Silva AA, Lopez AR, Martynhak BJ, et al. Clock polymorphisms and circadian rhythms phenotypes in a sample of the Brazilian population. Chronobiol Int 2007; 24: 1-8.
102. Serretti A, Benedetti F, Mandelli L, Lorenzi C, Pirovano A, Colombo C, et al. Genetic dissection of psychopathological symptoms: Insomnia in mood disorders and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 2003; 121B: 35-8.
103. Serretti A, Cusin C, Benedetti F, Mandelli L, Pirovano A, Zanardi R, et al. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am J Med Genet B, Neuropsychiatr Genet 2005; 137B: 36-9.
104. Benedetti F, Dallaspezia S, Fulgosi MC, Lorenzi C, Serretti A, Barbini B, et al. Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 631-5.
105. Bae K, Jin XW, Maywood ES, Hastings MH, Reppert SM, Weaver DR. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 2001; 30: 525-36.
106. Carpen JD, von Schantz M, Smits M, Skene DJ, Archer SN. A silent polymorphism in the PERI gene associates with extreme diurnal preference in humans. J Hum Genet 2006; 51: 1122-5.
107. Katzenberg D, Young T, Lin L, Finn L, Mignot E. A human period gene (HPERI) polymorphism is not associated with diurnal preference in normal adults. Psychiatr Genet 1999; 9: 107-9.
108. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, et al. An hPer2 phosphorylation site mutation in familiar advanced sleep phase syndrome. Science 2001; 291: 1040-3.
109. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, et al. Functional consequences of a CKI delta mutation causing familial advanced sleep phase syndrome. Nature 2005; 434: 640-4.
110. Xu Y, Toh KL, Jones CR, Shin JY, Fu YH, Ptacek LJ. Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell 2007; 128: 59-70.
111. Carpen JD, Archer SN, Skene DJ, Smits M, von Schantz M. A single-nucleotide polymorphism, in the 5 ′-untranslated region of the hPER2 gene is associated with diurnal preference. J Sleep Res 2005; 14: 293-7.
112. Archer SN, Robilliard DL, Skene DJ, Smits M, Williams A, Arendt J, et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003; 26: 413-5.
113. Pereira DS, Tufik S, Louzada FM, Benedito-Silva AA, Lopez AR, Lemos NA, et al. Association of the length polymorphism delayed sleep-phase syndrome: Does in the human Per3 gene with the latitude have an influence upon it? Sleep 2005; 28: 29-32.
114. Viola AU, Archer SN, James LM, Groeger JA, Lo JC, Skene DJ, et al. PER3 polymorphism predicts sleep structure and waking performance. Curr Biol 2007; 17: 613-8.
115. Groeger JA, Viola AU, Lo JCY, von Schantz M, Archer SN, Dijk DJ. Early morning executive fuctioning during sleep deprivation is compromised by a PERIOD3 polymorphism. Sleep 2008; 31: 1159-67.
116. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007; 87: 659-797.
117. Hirschhorn R, Yang DR, Israni A. An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent intragenic crossover. Ann Hum Genet 1994; 58: 1-9.
118. Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Trillo S, et al. Adenosine deaminase alleles and autistic disorder: case-control and family-based association studies. Am J Med Genet 2000; 96: 784-90.
119. Battistuzzi G, Iudicone P, Santolamazza P, Petrucci R. Activity of adenosine deaminase allelic forms in intact erythrocytes and in lymphocytes. Ann Hum Genet 1981; 45: 15-9.
120. Bottini N, De Luca D, Saccucci P, Fiumara A, Elia M, Porfirio MC, et al. Autism: Evidence of association with adenosine deaminase genetic polymorphism. Neurogenet 2001; 3: 111-3.
121. Rétey JV, Adam M, Honegger E, Khatami R, Luhmann UFO, Jung HH, et al. A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc Natl Acad Sci USA 2005; 102: 15676-81.
122. Franken P, Chollet D, Tafti M. The homeostatic regulation of sleep need is under genetic control. J Neurosci 2001; 21: 2610-21.
123. Radulovacki M, Virus RM, Djuricic-Nedelson M, Green RD. Hypnotic effects of deoxycorformycin in rats. Brain Res 1983; 271: 392-5.
124. Okada T, Mochizuki T, Huang ZL, Eguchi N, Sugita Y, Urade Y, et al. Dominant localization of adenosine deaminase in leptomeninges and involvement of the enzyme in sleep. Biochem Biophys Res Comm 2003; 312: 29-34.
125. Koch H, Craig I, Dahlitz M, Denney R, Parkes D. Analysis of the monoamine oxidase genes and the Norrie disease gene locus in narcolepsy. Lancet 1999; 353: 645-6.
126. Dauvilliers Y, Neidhart E, Lecendreux M, Billiard M, Tafti M. MAO-A and COMT polymorphisms and gene effects in narcolepsy. Mol Psychiatry 2001; 6: 367-72.
127. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-50.
128. Chen JS, Lipska BK, Halim N, Ma QD, Matsumoto M, Methem S, et al. Functional analysis of genetic variation in catecbol-o-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 2004; 75: 807-21.
129. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 2003; 23: 2008-13.
130. Wieczorek S, Jagiello P, Arning L, Dahmen N, Epplen JT. Screening for candidate gene regions in narcolepsy using a microsatellite based approach and pooled DNA. J Mol Med 2004; 82: 696-705.
131. Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJM, Papanicolaou GJ, et al. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 2007; 64: 783-92.
132. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-31.
133. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 1998; 155: 207-13.
134. David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R, et al. A functional genetic variation of the serotonin (5- HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 2005; 25: 2586-90.
135. Brummett BH, Krystal AD, Ashley-Koch A, Kuhn CM, Zuchner S, Siegler IC, et al. Sleep quality varies as a function of 5-HTTLPR genotype and stress. Psychosom Med 2007; 69: 621-4.
136. Linn S, McClure T, Monaghan K, Blulun D, Watson K, Roth T, et al. Association of serotonin transporter (5HTT) gene polymorphism with amount of slow-wave sleep in human subjects. Sleep 2007; 30: A365.
137. Benedetti F, Serretti A, Colombo C, Campori E, Barbini B, di Bella D, et al. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry 1999; 156: 1450-2
138. Wisor JP, Wurts SW, Hall FS, Lesch KP, Murphy DL, Uhl GR, et al. Altered rapid eye movement sleep timing in serotonin transporter knockout mice. Neuroreport 2003; 14: 233-8.
139. Boutrel B, Monaca C, Hen R, Hamon M, Adrien J. Involvement of 5-HT1A receptors in homeostatic and stress-induced adaptive regulations of paradoxical sleep: Studies in 5-HT1A knock-out mice. J Neuroscience 2002; 22: 4686-92.
140. Landolt HP, Meier V, Burgess HJ, Finelli LA, Cattelin F, Achermann P, et al. Serotonin-2 receptors and human sleep: Effect of a selective antagonist on EEG power spectra. Neuropsychopharmacology 1999; 21: 455-66.
141. Wafford KA, Ebert B. Emerging anti-insomnia drugs: Tackling sleeplessness and the quality of wake time. Nature Rev Drug Disc 2008; 7: 530-40.
142. Gottlieb DJ, O'Connor GT, Wilk JB. Genome-wide association of sleep and circadian phenotypes. BMC Med Genet 2007; 8(Suppl 1): S9.
143. Johns MW. A New Method for Measuring Daytime Sleepiness - the Epworth Sleepiness Scale. Sleep 1991; 14: 540-5.
144. Landolt HP. Sleep homeostasis: A role for adenosine in humans? Biochem Pharmacol 2008; 75: 2070-9.
145. Satoh S, Matsumura H, Hayaishi O. Involvement of adenosine A(2a) receptor in sleep promotion. Eur J Pharmacol 1998; 351: 155-62.
146. Satoh S, Matsumura H, Koike N, Tokunaga Y, Maeda T, Hayaishi O. Region-dependent difference in the sleep-promoting potency of an adenosine A(2A) receptor agonist. Eur J Neurosci 1999; 11: 1587-97.
147. Scammell TE, Gerashchenko DY, Mochizuki T, McCarthy MT, Estabrooke IV, Sears CA, et al. An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience 2001; 107: 653-63.
148. Methippara MM, Kumar S, Alam MN, Szymusiak R, McGinty D. Effects on sleep of microdialysis of adenosine A(1) and A(2a) receptor analogs into the lateral preoptic area of rats. Am J Physiol 2005; 289: R1715-R23.
149. 2A receptor are involved in the homeostatic regulation of NREM sleep. Arch Ital Biol 2004; 142: 533-9.
150. 2A, but not A1, receptors mediate the arousal effect of caffeine. Nature Neurosci 2005; 8: 858-9.
151. Alsene K, Deckert J, Sand P, de Wit H. Association between A(2a) receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003; 28: 1694-702.
152. Perlis ML, Merica H, Smith MT, Giles DE. Beta EEG activity and insomnia. Sleep Med Rev 2001; 5: 365-76.
153. Chait LD. Factors Influencing the Subjective Response to Caffeine. Behav Pharmacol 1992; 3: 219-28.
154. Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2008; 33: In press.
155. 2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr 2007; 86: 240-4.
156. Dauvilliers Y, Neidhart E, Billiard M, Tafti M. Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. Pharmacogenomics J 2002; 2: 65-8.
157. Madras BK, Xie ZH, Lin ZC, Jassen A, Panas H, Lynch L, et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 2006; 319: 561-9.
158. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, et al. Catechol O-methyltransferase val(158)-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 2003; 100: 6186-91.